ATE419859T1 - Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut - Google Patents

Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut

Info

Publication number
ATE419859T1
ATE419859T1 AT05778952T AT05778952T ATE419859T1 AT E419859 T1 ATE419859 T1 AT E419859T1 AT 05778952 T AT05778952 T AT 05778952T AT 05778952 T AT05778952 T AT 05778952T AT E419859 T1 ATE419859 T1 AT E419859T1
Authority
AT
Austria
Prior art keywords
skin
topical compositions
protect
probiotic bacteria
produce topical
Prior art date
Application number
AT05778952T
Other languages
English (en)
Inventor
Giancarla Dondi
Patrizia Malfa
Original Assignee
Proge Farm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proge Farm Srl filed Critical Proge Farm Srl
Application granted granted Critical
Publication of ATE419859T1 publication Critical patent/ATE419859T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT05778952T 2004-07-29 2005-07-28 Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut ATE419859T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001550A ITMI20041550A1 (it) 2004-07-29 2004-07-29 Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide

Publications (1)

Publication Number Publication Date
ATE419859T1 true ATE419859T1 (de) 2009-01-15

Family

ID=35058737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05778952T ATE419859T1 (de) 2004-07-29 2005-07-28 Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut

Country Status (7)

Country Link
EP (1) EP1778258B1 (de)
AT (1) ATE419859T1 (de)
DE (1) DE602005012276D1 (de)
ES (1) ES2320685T3 (de)
IT (1) ITMI20041550A1 (de)
PT (1) PT1778258E (de)
WO (1) WO2006013441A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2913337A1 (fr) * 2007-03-08 2008-09-12 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganismes
WO2009000875A2 (en) * 2007-06-27 2008-12-31 Chr. Hansen A/S Lactobacillus helveticus bacterium composition for treatment of atopic dermatitis
FR2945944B1 (fr) * 2009-06-02 2011-07-15 Oreal Procede cosmetique de traitement des etats pelliculaires comprenant l'administration d'un microorganisme probiotique et d'un actif antipelliculaire
CN102131495B (zh) * 2008-07-29 2017-07-04 欧莱雅 微生物用于治疗头皮病症的美容应用
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
DE102011009798B4 (de) * 2011-01-31 2015-03-05 Merz Pharma Gmbh & Co. Kgaa Balneologische lipidhaltige probiotische Zubereitungen für kosmetische / dermatologische / medizinische Anwendungen
US20140065209A1 (en) * 2011-05-03 2014-03-06 Dupont Nutrition Biosciences Aps Probiotic bacteria for the topical treatment of skin disorders
EP2836224A4 (de) 2012-02-29 2015-12-16 Ethicon Endo Surgery Inc Zusammensetzungen von biozönose und zugehörige verfahren
MX2015001751A (es) 2012-08-07 2015-11-13 Topgenix Inc Composicion topica comprendiendo bacterias transformadas que expresan un compuesto de interes.
FR2999601B1 (fr) 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
GR1008308B (el) 2013-05-31 2014-10-02 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
WO2015195546A1 (en) 2014-06-17 2015-12-23 TopGeniX, Inc. Topical formulations for uv protection
CA2964480A1 (en) 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP3436041B1 (de) 2016-03-31 2023-05-24 Gojo Industries, Inc. Zusammensetzung zur desinfektion, enthaltend einen probiotischen/prebiotischen bestandteil
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
ITUA20164065A1 (it) * 2016-06-01 2017-12-01 Probiotical Spa Composizioni in gel per applicazioni topiche a base di batteri, preparazione delle stesse e loro usi.
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
LT3755356T (lt) 2018-02-24 2025-09-10 Clearskin Ltd Kompozicijos, priemonės, sistemos, rinkiniai ir būdai odos ligos būklės gydymui
IT201800004036A1 (it) * 2018-03-28 2019-09-28 Teres Srl Gel transdermico
KR102138834B1 (ko) * 2018-05-23 2020-07-29 주식회사 고바이오랩 락토바실러스 가세리 kbl697 균주 및 그 용도
CA3101173A1 (en) * 2018-05-23 2019-11-28 Ko Biolabs, Inc. Lactobacillus crispatus kbl693 strain and use thereof
EP3823651A4 (de) 2018-07-19 2022-04-27 Pendulum Therapeutics, Inc. Verfahren und zusammensetzungen zur mikrobiellen transplantation
AU2019379234B2 (en) 2019-01-04 2026-04-09 L'ORéAL S.A. Strains, composition and method of use
IT201900000801A1 (it) * 2019-01-18 2020-07-18 Proge Farm Srl Composizione comprendente batteri probiotici non vitali e suo uso in terapia
AU2020291622B2 (en) * 2019-06-13 2025-12-18 L'ORéAL S.A. A gel composition comprising viable microorganisms
FR3117340B1 (fr) * 2020-12-15 2024-01-05 Basf Beauty Care Solutions France Sas Utilisation cosmétique, nutraceutique ou dermatologique d’une souche deLactobacillus crispatus et / ou d’une composition la comprenant
JP2024543626A (ja) * 2021-12-10 2024-11-21 バイオティクス プライベート リミテッド 皮膚状態を改善するためのラクトバチルス・クリスパタス（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｃｒｉｓｐａｔｕｓ）細菌溶解物および／または細菌を含む組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296148B1 (it) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
EP1110555A1 (de) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Anti-adhäsives Agens für die pathogene Hautflora

Also Published As

Publication number Publication date
PT1778258E (pt) 2009-03-31
WO2006013441A2 (en) 2006-02-09
WO2006013441A3 (en) 2006-04-06
ITMI20041550A1 (it) 2004-10-29
DE602005012276D1 (de) 2009-02-26
ES2320685T3 (es) 2009-05-27
EP1778258A2 (de) 2007-05-02
EP1778258B1 (de) 2009-01-07

Similar Documents

Publication Publication Date Title
ATE419859T1 (de) Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut
EA200870019A1 (ru) Лактамовые соединения и способы их применения
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
EP2494059A4 (de) Verwendung von methylsulfonylmethan (msm) zur modulierung einer mikrobiellen aktivität
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
NO20083245L (no) Sykliske antimikrobielle peptider
DE602005015451D1 (de) Auf probiotischen bakterien basierende zusammensetzung und ihre verwendung zur vorbeugung und/oder behandlung von atemwegserkrankungen und/oder infektionen sowie zur verbesserung der darmtätigkeit
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
WO2007131072A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
ATE481134T1 (de) Zusammensetzungen und verwendung von tyrosinkinase-hemmern zur behandlung von pathogenen infektionen
CL2008002689A1 (es) Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia.
NO20082425L (no) Formuleringer omfattende jorumycin-, reni-eramycin-, safracin- eller saframycin-relaterte forbindelser for behandling av proliferative sykdommer
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
DE602004022689D1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
NO20055741L (no) Nye kjemiske forbindelser
ATE475651T1 (de) Aryl-substituierte heterozyklen und ihre verwendung
ATE524488T1 (de) Lysobactinamide
DE60313803D1 (de) Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen
IL178094A0 (en) Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
UY31131A1 (es) "oxazolidinonas sustituidas y su uso
MX2007010484A (es) Moleculas y metodos para usarlas para tratar enfermedades asociadas con mcp-1/ccr2.
ATE433459T1 (de) Desoxo-nonadepsipeptide
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
JO3046B1 (ar) اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها.
UA110918C2 (uk) Інгібітори протеїнфосфатази-1 та їх застосування

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties